Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan;
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10782-E10791. doi: 10.1073/pnas.1712484114. Epub 2017 Nov 29.
Signal peptide peptidase (SPP) is an intramembrane aspartic protease involved in the maturation of the core protein of hepatitis C virus (HCV). The processing of HCV core protein by SPP has been reported to be critical for the propagation and pathogenesis of HCV. Here we examined the inhibitory activity of inhibitors for γ-secretase, another intramembrane cleaving protease, against SPP, and our findings revealed that the dibenzoazepine-type structure in the γ-secretase inhibitors is critical for the inhibition of SPP. The spatial distribution showed that the γ-secretase inhibitor compound YO-01027 with the dibenzoazepine structure exhibits potent inhibiting activity against SPP in vitro and in vivo through the interaction of Val223 in SPP. Treatment with this SPP inhibitor suppressed the maturation of core proteins of all HCV genotypes without the emergence of drug-resistant viruses, in contrast to the treatment with direct-acting antivirals. YO-01027 also efficiently inhibited the propagation of protozoa such as and These data suggest that SPP is an ideal target for the development of therapeutics not only against chronic hepatitis C but also against protozoiasis.
信号肽肽酶(SPP)是一种跨膜天冬氨酸蛋白酶,参与丙型肝炎病毒(HCV)核心蛋白的成熟。据报道,SPP 对 HCV 核心蛋白的加工对于 HCV 的复制和发病机制至关重要。在这里,我们研究了另一种跨膜切割蛋白酶 γ-分泌酶抑制剂对 SPP 的抑制活性,我们的发现表明,γ-分泌酶抑制剂中的二苯并氮杂卓结构对于 SPP 的抑制是至关重要的。空间分布表明,具有二苯并氮杂卓结构的 γ-分泌酶抑制剂化合物 YO-01027 通过与 SPP 中的 Val223 相互作用,在体外和体内均表现出对 SPP 的强大抑制活性。与直接作用抗病毒药物治疗不同,用这种 SPP 抑制剂治疗可抑制所有 HCV 基因型核心蛋白的成熟,而不会出现耐药病毒。YO-01027 还能有效地抑制原生动物的繁殖,如 和 。这些数据表明,SPP 是开发治疗药物的理想靶点,不仅可用于治疗慢性丙型肝炎,还可用于治疗原生动物病。